Clinical benefit and toxicity of nivolumab plus ipilimumab in patients with advanced melanoma previously treated with checkpoint blockade inhibitors Meeting Abstract
| Authors: | Friedman, C. F.; Wolchok, J. D.; Postow, M. A.; Shoushtari, A. N.; Callahan, M. K.; Momtaz, P.; Chapman, P. B. |
| Abstract Title: | Clinical benefit and toxicity of nivolumab plus ipilimumab in patients with advanced melanoma previously treated with checkpoint blockade inhibitors |
| Meeting Title: | 2017 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2017 Feb 23-25 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-03-01 |
| Language: | English |
| ACCESSION: | WOS:000443282900097 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2017.35.7_suppl.100 |
| Notes: | Meeting Abstract: 100 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
